Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Developing a Novel Digital Therapeutic for the Treatment of Generalized Anxiety Disorder

NCT03683472 is registered in ClinicalTrials.gov with MindSciences, Inc. as lead sponsor.

NCT NCT03683472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03683472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Developing a Novel Digital Therapeutic for the Treatment of Generalized Anxiety Disorder
Lead sponsor
MindSciences, Inc.
Phase
Not applicable
Overall status
Completed
Start date
May 20, 2019
Completion date
October 17, 2019
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorders